Gut Bacteria Changes Predict Cognitive Decline Before Symptoms Appear

This groundbreaking multiomics study examined the gut-brain axis across the full spectrum of cognitive decline, from healthy individuals to dementia patients, revealing that gut microbiome disruption begins much earlier than previously recognized.

Researchers analyzed 278 plasma samples and 267 fecal samples from participants at Geneva Memory Center, measuring gut bacteria composition, inflammatory cytokines, and metabolites. The study included healthy controls, subjective cognitive decline (SCD), mild cognitive impairment (MCI), and dementia patients.

Key findings showed progressive gut dysbiosis with cognitive decline. Beneficial short-chain fatty acid-producing bacteria (Firmicutes and Bacteroidota) dropped dramatically from 76% and 17% in healthy controls to 59% and 11% in dementia patients. Harmful bacteria increased, with Proteobacteria rising from under 2% to 4% and Verrucomicrobiota from 3% to 11%. Notably, Ruminococcus gnavus, a mucus-degrading species linked to inflammation, increased significantly in dementia.

The study revealed that fecal metabolites changed before plasma markers, suggesting gut-based biomarkers could enable earlier detection. Alterations in bile acids, trimethylamine N-oxide, fatty acids, and other bacteria-derived compounds correlated with cognitive decline severity. Importantly, these changes were detectable even in SCD—the earliest stage where people notice cognitive changes but tests remain normal.

These findings suggest the gut microbiome could serve as an early warning system for cognitive decline, potentially enabling interventions before irreversible brain damage occurs. However, larger longitudinal studies are needed to validate these promising results.